Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine 1 mg/day for ocular involvement in Behcet's disease
IRCT138808062641N1Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of colchicine in Behçet's disease (BD), sponsored by Tehran University of Medical Sciences. Started Jan 2010; status: completed.
02
Drugs
colchicine
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on IRCT138808062641N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138808062641N1.